These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 15950328)

  • 1. Molecular and biological characterization of simian-human immunodeficiency virus-like particles produced by recombinant fowlpox viruses.
    Zanotto C; Paganini M; Elli V; Basavecchia V; Neri M; De Giuli Morghen C; Radaelli A
    Vaccine; 2005 Sep; 23(39):4745-53. PubMed ID: 15950328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
    Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
    J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation in rabbits of different anti-SHIV vaccine strategies based on DNA/fowlpox priming and virus-like particle boosting.
    Zanotto C; Elli V; Basavecchia V; Brivio A; Paganini M; Pinna D; Vicenzi E; De Giuli Morghen C; Radaelli A
    FEMS Immunol Med Microbiol; 2003 Jan; 35(1):59-65. PubMed ID: 12589958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3.
    Kent SJ; Dale CJ; Ranasinghe C; Stratov I; De Rose R; Chea S; Montefiori DC; Thomson S; Ramshaw IA; Coupar BE; Boyle DB; Law M; Wilson KM; Ramsay AJ
    Vaccine; 2005 Oct; 23(42):5009-21. PubMed ID: 15985317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease.
    McKenna PM; Koser ML; Carlson KR; Montefiori DC; Letvin NL; Papaneri AB; Pomerantz RJ; Dietzschold B; Silvera P; McGettigan JP; Schnell MJ
    J Infect Dis; 2007 Apr; 195(7):980-8. PubMed ID: 17330788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with HIV-1 SF162-derived Envelope gp140 proteins does not protect macaques from heterologous simian-human immunodeficiency virus SHIV89.6P infection.
    Xu R; Srivastava IK; Kuller L; Zarkikh I; Kraft Z; Fagrouch Z; Letvin NL; Heeney JL; Barnett SW; Stamatatos L
    Virology; 2006 Jun; 349(2):276-89. PubMed ID: 16527321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prime-boost immunization with DNA, recombinant fowlpox virus and VLP(SHIV) elicit both neutralizing antibodies and IFNgamma-producing T cells against the HIV-envelope protein in mice that control env-bearing tumour cells.
    Radaelli A; Bonduelle O; Beggio P; Mahe B; Pozzi E; Elli V; Paganini M; Zanotto C; De Giuli Morghen C; Combadière B
    Vaccine; 2007 Mar; 25(11):2128-38. PubMed ID: 17241705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fowlpox virus vaccines for HIV and SHIV clinical and pre-clinical trials.
    Coupar BE; Purcell DF; Thomson SA; Ramshaw IA; Kent SJ; Boyle DB
    Vaccine; 2006 Feb; 24(9):1378-88. PubMed ID: 16257479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of immune responses and cytokine profiles elicited in rabbits by the combined use of recombinant fowlpox viruses, plasmids and virus-like particles in prime-boost vaccination protocols against SHIV.
    Radaelli A; Zanotto C; Perletti G; Elli V; Vicenzi E; Poli G; De Giuli Morghen C
    Vaccine; 2003 May; 21(17-18):2052-64. PubMed ID: 12706695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and efficacy of immunodeficiency virus-like particles pseudotyped with the G protein of vesicular stomatitis virus.
    Kuate S; Stahl-Hennig C; Stoiber H; Nchinda G; Floto A; Franz M; Sauermann U; Bredl S; Deml L; Ignatius R; Norley S; Racz P; Tenner-Racz K; Steinman RM; Wagner R; Uberla K
    Virology; 2006 Jul; 351(1):133-44. PubMed ID: 16616946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral outcome of simian-human immunodeficiency virus SHIV-89.6P adapted to cynomolgus monkeys.
    Borsetti A; Baroncelli S; Maggiorella MT; Bellino S; Moretti S; Sernicola L; Belli R; Ridolfi B; Farcomeni S; Negri DR; Cafaro A; Ensoli B; Titti F
    Arch Virol; 2008; 153(3):463-72. PubMed ID: 18080858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate anti-viral immunity is associated with the protection elicited by the simian immunodeficiency virus (SIV) live attenuated virus vaccine in cynomolgus monkeys.
    Goletti D; Macchia I; Leone P; Pace M; Sernicola L; Pavone-Cossut MR; Maggiorella MT; Cafaro A; Ensoli B; Titti F
    Med Sci Monit; 2006 Oct; 12(10):BR330-40. PubMed ID: 17006396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canarypox and fowlpox viruses as recombinant vaccine vectors: an ultrastructural comparative analysis.
    Pacchioni S; Volonté L; Zanotto C; Pozzi E; De Giuli Morghen C; Radaelli A
    Arch Virol; 2010 Jun; 155(6):915-24. PubMed ID: 20379750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.
    Braun SE; Wong FE; Connole M; Qiu G; Lee L; Gillis J; Lu X; Humeau L; Slepushkin V; Binder GK; Dropulic B; Johnson RP
    Mol Ther; 2005 Dec; 12(6):1157-67. PubMed ID: 16168713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentivirus-like particles without reverse transcriptase elicit efficient immune responses.
    McBurney SP; Young KR; Nwaigwe CI; Soloff AC; Cole KS; Ross TM
    Curr HIV Res; 2006 Oct; 4(4):475-84. PubMed ID: 17073623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Live attenuated measles vaccine expressing HIV-1 Gag virus like particles covered with gp160DeltaV1V2 is strongly immunogenic.
    Guerbois M; Moris A; Combredet C; Najburg V; Ruffié C; Février M; Cayet N; Brandler S; Schwartz O; Tangy F
    Virology; 2009 May; 388(1):191-203. PubMed ID: 19345390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Selection of recombinant fowlpox virus coexpressing HIV-1 gag-gp120 and IL-6].
    Jiang WZ; Jin NY; Li ZJ; Zhang LS; Zou XH; Wang TD
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Sep; 19(3):267-70. PubMed ID: 16261213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimeric adenovirus type 5/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian/human immunodeficiency virus in monkeys.
    Someya K; Xin KQ; Ami Y; Izumi Y; Mizuguchi H; Ohta S; Yamamoto N; Honda M; Okuda K
    Virology; 2007 Oct; 367(2):390-7. PubMed ID: 17628628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient production of Rift Valley fever virus-like particles: The antiviral protein MxA can inhibit primary transcription of bunyaviruses.
    Habjan M; Penski N; Wagner V; Spiegel M; Overby AK; Kochs G; Huiskonen JT; Weber F
    Virology; 2009 Mar; 385(2):400-8. PubMed ID: 19155037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA vaccination of macaques by a full-genome SHIV plasmid that has an IL-2 gene and produces non-infectious virus particles.
    Horiuchi R; Akahata W; Kuwata T; Enose Y; Ido E; Suzuki H; Miyake A; Saito N; Ibuki K; Goto T; Miura T; Hayami M
    Vaccine; 2006 Apr; 24(17):3677-85. PubMed ID: 16085341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.